Chimeric Antigen Receptor T (CAR-T) Cells Market Report 2023 | Market Size, Trends, And Market Forecast 2023-2032 | Novartis International AG, Pfizer Inc., Gilead Sciences Inc., Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited

Chimeric Antigen Receptor T (CAR-T) Cells Market Size

The Business Research Company’s Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023 evaluates chimeric antigen receptor T (CAR-T) cells market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8124&type=smp

The global chimeric antigen receptor T (CAR-T) cells market size is expected to grow from $1.96 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chimeric antigen receptor T (CAR-T) cells market size is expected to grow to $10.24 billion in 2027 at a CAGR of 38.8%.

The Chimeric Antigen Receptor T (CAR-T) Cells Market Segments In The Report Are:

Chimeric Antigen Receptor T (CAR-T) Cells By Target Antigen:
CD19
CD22
Other Antigens

Chimeric Antigen Receptor T (CAR-T) Cells By Application:
Acute Lymphoblastic Leukemia
Diffuse Large B-Cell Lymphoma
Other Applications

Chimeric Antigen Receptor T (CAR-T) Cells By End User:
Hospitals
Cancer Research Centres
Clinics

Top Key Players:

Novartis International AG
Pfizer Inc.
Gilead Sciences Inc.
Autolus Therapeutics Plc
CARsgen Therapeutics Company Limited

North America was the largest region in the chimeric antigen receptor T (CAR-T) cells market in 2022.

Get More Information On The Chimeric Antigen Receptor T (CAR-T) Cells Market Report:

https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report

The table of contents in TBRC’s chimeric antigen receptor T (CAR-T) cells market report includes:

1. Executive Summary
2. Chimeric Antigen Receptor T (CAR-T) Cells Market Characteristics
3. Chimeric Antigen Receptor T (CAR-T) Cells Market Trends And Strategies
4. Chimeric Antigen Receptor T (CAR-T) Cells Market – Macro Economic Scenario
5. Chimeric Antigen Receptor T (CAR-T) Cells Market Size And Growth
…..
26. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market
27. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Chimeric Antigen Receptor T (CAR-T) Cells Market
29. Chimeric Antigen Receptor T (CAR-T) Cells Market Future Outlook and Potential Analysis
30. Appendix

List Of Tables

Table 1: Global Historic Market Growth, 2017-2022, $ Billion

Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion

Table 3: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 4: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 5: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
…..
Table 46: Novartis International AG Financial Performance

Table 47: Pfizer Inc Financial Performance

Table 48: Gilead Sciences Inc Financial Performance

Table 49: Autolus Therapeutics Plc Financial Performance

Table 50: CARsgen Therapeutics Company Limited Financial Performance

Read Related Reports:
https://www.openpr.com/news/3035831/aspirin-market-outlook-size-share-industry-trends-report

https://www.openpr.com/news/3035843/2023-global-eylea-market-size-share-growth-trends

https://www.openpr.com/news/3035867/gene-expression-market-size-growth-drivers-trends-and-global

https://topprnews.com/demand-response-management-systems-market-size/

https://topprnews.com/electrophoresis-reagents-market-trends/

https://topprnews.com/electric-aircraft-market-growth/

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model